Monounsaturated fat

Monounsaturated Fat (MUFA): A Comprehensive Reference

1. Identity: Chemical Names, Nomenclature, and Classification

A monounsaturated fatty acid (MUFA) is a fatty acid having one carbon-carbon double bond in its carbon chain. Fatty acids are carboxylic acids that are structural components of fats and oils; they usually contain an even number of carbon atoms (typically 12–20), and can be classified by the presence and number of carbon-to-carbon double bonds. The term "monounsaturated" therefore distinguishes these molecules from saturated fatty acids (no double bonds) and polyunsaturated fatty acids (two or more double bonds).

Monounsaturated fatty acids — also called monoenoic fatty acids — are widespread in the living world and occur mostly as their cis-isomers; they have the general structure CH₃(CH₂)ₓCH═CH(CH₂)yCOOH. In naturally occurring fatty acids, introducing a double bond into the long hydrocarbon chain causes the chain to adopt a "kink" (cis geometry). Oleic acid, a monounsaturated fatty acid with molecular formula C₁₈H₃₄O₂, with this kink is called cis-oleic acid.

Principal Monounsaturated Fatty Acids

• Oleic acid (18:1 n−9; cis-9-octadecenoic acid): Oleic acid has 18 carbon atoms with the first double bond occurring 9 carbon atoms away from the carboxylic acid group. The most common MUFA in daily nutrition is oleic acid, followed by palmitoleic acid and vaccenic acid; oleic acid represents the topmost MUFA provided in the diet, accounting for approximately 90% of all MUFA consumed.
• Palmitoleic acid (16:1 n−7): Palmitoleic acid has 16 carbon atoms with the first double bond occurring 7 carbon atoms away from the methyl group (and 9 carbons from the carboxyl end); it can be lengthened to the 18-carbon cis-vaccenic acid.
• Cis-vaccenic acid (18:1 n−7): Palmitoleic acid and cis-vaccenic acid occur in small amounts in fats.

The most common MUFAs are of the n-9 series, such as oleic acid from olive oil (cis-9-octadecenoic acid), and from almost all seed oils. Several positional isomers of oleic acid exist with the cis double bond in the (n-12) or (n-7) position; trans-isomers are also known — elaidic acid (t9-octadecenoic acid) and t-vaccenic acid (t11-octadecenoic acid) are found in the rumen and in lipids of ruminant animals.

Physical and Chemical Properties

Fatty acid viscosity and melting temperature increase with decreasing number of double bonds; therefore, monounsaturated fatty acids have a higher melting point than polyunsaturated fatty acids and a lower melting point than saturated fatty acids. Monounsaturated fatty acids are liquids at room temperature and semisolid or solid when refrigerated, resulting in an isotopic lattice structure.

In addition to obtaining MUFAs from the diet, MUFA can also be synthesized by elongase and desaturase enzymes from saturated fatty acids primarily derived from de novo lipogenesis. Saturated and monounsaturated fatty acids can be synthesized de novo by the brain, whereas polyunsaturated fatty acids are mainly obtained from the blood.

2. Natural Sources and Common Forms/Preparations

Monounsaturated fats are found in animal flesh such as red meat, whole milk products, nuts, and high-fat fruits such as olives and avocados. Several plant oils stand out as particularly concentrated dietary sources:

• Algal oil is approximately 92% monounsaturated fat.
• Olive oil is approximately 75% monounsaturated fat. It consists mainly of oleic acid (up to 83%), with smaller amounts of other fatty acids including linoleic acid (up to 21%) and palmitic acid (up to 20%).
• The high-oleic variety of sunflower oil contains at least 70% monounsaturated fat.
• Avocados contain a MUFA-rich fruit oil with 71% MUFA, 13% polyunsaturated fatty acids (PUFA), and 16% saturated fatty acids (SFA).
• Canola oil and cashews are both approximately 58% monounsaturated fat.
• Tallow (beef fat) is approximately 50% monounsaturated fat, and lard is approximately 40% monounsaturated fat.

Monounsaturated fat sources include non-tropical plant-based oils such as olive, canola, peanut, safflower, and sesame oils, as well as avocados, nuts, and seeds.

Common Forms and Preparations

MUFAs are consumed primarily in whole-food form or as extracted oils. Extra virgin olive oil (EVOO) is required to have no more than 0.8% free acidity and is considered to have favorable flavor characteristics. Monounsaturated fats are generally available as triglycerides containing one unsaturated fatty acid; almost invariably that fatty acid is oleic acid (18:1 n−9). Specific refined or concentrated MUFA preparations — including high-oleic sunflower oil and avocado oil — are also commercially available, as are whole-food sources such as tree nuts, olives, and avocados.

3. Traditional and Historical Use

The concept of "monounsaturated fat" as a discrete nutritional category is a modern scientific designation, but the food sources richest in MUFAs — particularly olive oil — have millennia-long histories of use across multiple civilizations. Olive oil has long been a common ingredient in Mediterranean cuisine, including ancient Greek and Roman cuisine; wild olives, which originated in Asia Minor, were collected by Neolithic people as early as the 8th millennium BC.

Ancient civilizations such as the Egyptians, Greeks, Romans, and Phoenicians cultivated olive trees, recognizing the oil's medicinal, culinary, and spiritual significance; olive oil was used not only as food but also as a healing agent, a form of currency, and even as fuel for lamps. The Romans, in particular, played a pivotal role in expanding olive cultivation across their empire, ensuring that olive oil became an essential part of Mediterranean culture.

The Mediterranean diet originates in the food cultures of ancient civilizations that developed around the Mediterranean Basin, and is based on the regular consumption of olive oil as the main source of added fat, together with plant foods — cereals, fruits, vegetables, legumes, tree nuts, and seeds — and moderate consumption of fish, seafood, and dairy.

The formal scientific study of MUFAs in the context of chronic disease prevention began in the mid-twentieth century. A few decades ago, the Mediterranean diet drew the attention of medical professionals by proving extended health benefits; the first reports ascertained cardiovascular protection, as multiple large-scale clinical studies, starting with Ancel Keys' Seven Countries Study, showed a marked reduction of atherosclerotic clinical events in populations with a Mediterranean dietary pattern.

Neutral effects of MUFA on plasma cholesterol levels in humans were first reported in the late 1950s and early 1960s by Keys et al., who used olive oil as the source of MUFA. Later, Mattson and Grundy used oleinate as the source of MUFA and suggested that MUFA may be a preferred candidate for saturated fatty acid replacement in the diet, because lower LDL cholesterol was found with their MUFA-enriched diet without any lowering of HDL cholesterol concentrations.

4. Key Constituents and Mechanisms of Action

Primary Active Compounds

By chemical definition, MUFAs are fatty acids that have only one unsaturated carbon bond; oleic acid (OA; 18:1n–9) and palmitoleic acid (PO; 16:1n–7) are the most common MUFAs, although many less abundant MUFA species exist.

Lipid and Lipoprotein Metabolism

Compared with saturated fatty acids, MUFAs lower total and LDL cholesterol levels; and relative to carbohydrate, they increase HDL cholesterol levels and decrease plasma triglyceride levels. Replacing dietary saturated fatty acids (SFAs) with monounsaturated fatty acids (MUFAs) lowers LDL cholesterol, but the underlying mechanisms remain unclear.

Omega-9 fatty acids such as oleic acid decrease cholesterol ester transfer protein (CETP) levels, a protein that mediates the transfer of cholesteryl esters from HDL to apolipoprotein B-containing lipoproteins; the isoenergetic replacement of a high-saturated fatty acid diet by a MUFA or a high-carbohydrate low-fat diet has been shown to decrease CETP concentration in young, healthy, normolipidemic subjects.

Blood Pressure Modulation

Oleic acid has been directly implicated in blood pressure reduction by increasing cell membrane fluidity and exerting hypotensive effects via the α2-adrenergic receptor system. Monounsaturated fatty acids have either neutral or hypotensive effects on blood pressure when compared to carbohydrate-rich, saturated fatty acid, or polyunsaturated fatty acid diets.

Inflammation Pathways

MUFAs can inhibit NF-κB and NLRP3 activation, respectively, through direct binding to GPR120 (G-protein coupled receptor 120) or PPARs (peroxisome proliferator-activated receptors), and through AMPK (AMP-activated protein kinase) phosphorylation; by inhibiting macrophage M1 polarization, MUFAs potentiate M2 polarization.

In the 3T3-L1 murine preadipocyte cell line, oleate treatment increases expression of the adiponectin gene, probably through PPARγ activation; adiponectin induces IL-10 secretion and inhibits IL-6 and TNF-α secretion, which has the potential to reduce local inflammation in vivo.

GPR120 interacts with MUFAs, especially palmitoleate; the activation of GPR120 by palmitoleate is involved in the resolution of palmitate-induced inflammation through a reduction of NF-κB activity.

Endogenous Biosynthesis

The Stearoyl-CoA desaturase-1 (SCD1) enzyme is a central regulator of lipid metabolism and fat storage; this enzyme catalyzes the generation of MUFAs — major components of triglycerides stored in lipid droplets — from saturated fatty acid substrates.

Oxidative Stability

Compared to polyunsaturated fatty acids, MUFAs are considerably more resistant to oxidation due to possessing only one double bond. Evidence from controlled clinical studies has shown that MUFAs favorably affect a number of risk factors for coronary heart disease (CHD), including plasma lipids and lipoproteins, factors related to thrombogenesis, in vitro LDL oxidative susceptibility (compared with PUFA), and insulin sensitivity. This relative resistance to oxidation also contributes to the greater thermal and storage stability of MUFA-rich oils, such as olive oil, compared with polyunsaturated-rich oils.

5. Scientific Evidence by Area of Use

5.1 Cardiovascular Disease Risk

Evidence Strength: Moderate-to-Strong (for plant-source MUFAs, particularly olive oil); Mixed for MUFAs from mixed or animal sources.

A meta-analysis of cohort studies aimed to focus on monounsaturated fat and cardiovascular disease, cardiovascular mortality, and all-cause mortality; literature was searched using PUBMED and EMBASE until June 2014; study-specific risk ratios and hazard ratios were pooled using an inverse variance random effect model; 32 cohort studies (42 reports) including 841,211 subjects met the objectives and were included.

The comparison of the top versus bottom third of the distribution of a combination of MUFA (of both plant and animal origin), olive oil, oleic acid, and MUFA:SFA ratio in each study resulted in significant risk reduction for all-cause mortality (RR: 0.89, 95% CI 0.83–0.96, p = 0.001) and cardiovascular mortality (RR: 0.88, 95% CI 0.80–0.96, p = 0.004).

The results indicate an overall risk reduction of all-cause mortality (11%), cardiovascular mortality (12%), cardiovascular events (9%), and stroke (17%) when comparing the top versus bottom third of MUFA, olive oil, oleic acid, and MUFA:SFA ratio; MUFA of mixed animal and vegetable sources per se did not yield any significant effects on these outcome parameters; however, only olive oil seems to be associated with reduced risk.

The European Food Safety Authority Panel on Dietetic Products, Nutrition and Allergies approved health claims on olive oil for protection by its polyphenols against oxidation of blood lipids and for the contribution to the maintenance of normal blood LDL-cholesterol levels by replacing saturated fats in the diet with oleic acid (Commission Regulation (EU) 432/2012 of 16 May 2012).

In the United States, the FDA allows producers of olive oil to place the following qualified health claim on product labels: "Limited and not conclusive scientific evidence suggests that eating about 2 tbsp. (23 g) of olive oil daily may reduce the risk of coronary heart disease due to the monounsaturated fat in olive oil."

The landmark PREDIMED (Prevención con Dieta Mediterránea) trial provided pivotal large-scale clinical evidence. The PREDIMED randomized controlled trial showed that a dietary pattern with an intake that reaches and even exceeds 40% of energy from fats can decrease the occurrence of myocardial infarction, stroke, and cardiovascular death; in this trial, the Mediterranean-style diet was supplemented with additional olive oil as the main source of fat, which agrees with the potential relevance of the MUFA oleic acid to prevent the development of cardiovascular risk.

The evidence also underscores the importance of dietary context: the effects of MUFA are sometimes overshadowed by those of polyunsaturated fatty acids, given that many studies are based on the replacement of carbohydrates with unsaturated fat; despite these considerations, it seems logical to posit that the most beneficial replacement would involve substituting saturated fatty acids with MUFA, although this area may not have been extensively studied.

5.2 Blood Lipid Profiles

Evidence Strength: Moderate (strong for LDL-cholesterol reduction when replacing SFA; evidence for HDL effects is more nuanced).

One systematic review and meta-analysis analyzed long-term, randomized, controlled dietary intervention trials to investigate the effects of MUFA on biomarkers of obesity and cardiovascular risk factors; dietary regimens with a high amount of MUFA (>12% of energy) were compared to those with ≤12%; the biomarkers assessed included weight, waist circumference, fat mass, total cholesterol, LDL cholesterol, HDL cholesterol, triacylglycerols, systolic and diastolic blood pressure, and C-reactive protein.

One dose-response study found that replacing dietary SFA with progressively higher levels of MUFA led to reduced LDL cholesterol (−0.20 and −0.49 mmol/L after moderate and high MUFA diets, respectively, compared with the low-MUFA diet; p for trend <0.01); plasma triacylglycerol and HDL cholesterol were not significantly affected by the dietary intervention.

HDL and LDL subclass distributions were not significantly altered, but as a consequence of the overall LDL lowering, concentrations of atherogenic LDL-III were 25% lower after the high-MUFA diet than after the low-MUFA diet (p = 0.02); the effects of replacing dietary SFAs with MUFAs on lipoprotein metabolism appear to be almost exclusively limited to the LDL density class.

The possibility that selected dietary MUFA species may have different effects on cholesterol metabolism is supported by some human and animal studies; palmitoleic acid has been reported to increase total plasma cholesterol and LDL cholesterol compared with oleic acid in hypercholesterolemic individuals, but appears to provide a more favorable lipid and lipoprotein profile compared with a typical Western diet.

5.3 Blood Glucose, Insulin Sensitivity, and Type 2 Diabetes

Evidence Strength: Moderate (consistent signal for improved HbA1c; less consistent for fasting glucose and insulin).

Dietary guidelines on macronutrient intake to improve glucose-insulin profiles and reduce or prevent type 2 diabetes generally recommend increasing foods rich in monounsaturated fat and reducing saturated fat; yet these guidelines have also emphasized the major gaps in established evidence for effects of dietary fats and carbohydrates on glucose-insulin homeostasis, including uncertainty as to whether benefits of MUFA in some trials were confounded by caloric restriction.

One systematic review focused on the effects of diets high in MUFA versus diets low in MUFA on important risk factors of type 2 diabetes, including plasma glucose, insulin, homeostasis model assessment of insulin resistance, and glycosylated haemoglobin (HbA1c); nine randomized controlled intervention trials with a total of 1,547 participants and a running time of at least 6 months, comparing diets high versus low in MUFA among adults with abnormal glucose metabolism, were included in the meta-analysis.

Significant differences in HbA1c were found (weighted mean difference −0.21%, 95% CI −0.40 to −0.02; p = 0.03), favouring the high MUFA groups; in contrast, fasting plasma glucose, fasting plasma insulin, and the homeostasis model assessment of insulin resistance were not affected by the amounts of MUFA in the dietary protocols; the review concluded that high-MUFA diets appear to be effective in reducing HbA1c and should be considered in dietary regimes for type 2 diabetes.

A separate meta-analysis compared diets high in cis-monounsaturated fatty acids to diets high in carbohydrates or in polyunsaturated fatty acids on metabolic risk factors in patients with type 2 diabetes. The analysis identified 24 studies totaling 1,460 participants comparing high-MUFA to high-carbohydrate diets.

Studies have shown that MUFAs have anti-inflammatory and anti-oxidative properties which positively affect insulin resistance; a systematic review examined the effects of MUFAs from different sources on insulin resistance in obese or overweight patients with or without metabolic syndrome. A search was carried out in PubMed/Medline and Bireme/VHL databases, and data from 16 studies were analysed; the intervention time ranged from 1 day to 5.2 years.

In contrast to their saturated counterparts, elevated intake of MUFAs can be associated with anti-inflammatory effects and improved insulin sensitivity; MUFA can improve blood lipid profiles, insulin sensitivity, and glucose control, while protecting β-cells against apoptosis. However, an increase in plasma MUFA levels can adversely influence incidence of type 2 diabetes; the evidence also indicates that there are differences in the metabolic effects between individual MUFAs, but only a few studies thus far have compared the effects of individual MUFAs.

In type 2 diabetic subjects, an oleic acid-rich diet exerted a hypoglycemic effect and reduced glycosylated hemoglobin in the long term.

5.4 Blood Pressure

Evidence Strength: Preliminary to Moderate; mostly neutral to modest hypotensive effects.

Cardiovascular benefits associated with MUFA include improved blood pressure, reduced total cholesterol, elevated HDL-C, and anti-inflammatory effects through the inhibition of inflammatory cytokine production.

MUFAs have either neutral or hypotensive effects on blood pressure when compared to carbohydrate-rich, saturated fatty acid, or polyunsaturated fatty acid diets; a few mechanisms have been associated with MUFAs, particularly the mechanism whereby oleic acid regulates membrane lipid structure to control G-protein-mediated signaling and reduce blood pressure.

5.5 Inflammation and Immune Modulation

Evidence Strength: Preliminary to Moderate; robust mechanistic data, but clinical human evidence remains limited.

Mediterranean diets have direct (via MUFAs, tocopherols, and polyphenols) and indirect (through low saturated fats and a well-balanced linoleic/alpha-linolenic acid ratio) effects on the immune system and inflammatory responses.

One randomized controlled trial showed that MUFA diets from oleic acid can reduce IL-6, a marker of inflammation; separately, intake of a high-MUFA (~20% of energy) diet for 12 weeks reduced postprandial MCP-1 and TNF-mRNAs in peripheral blood mononuclear cells compared to a high SFA diet.

It should be noted that not all in vitro findings are consistent with an anti-inflammatory role for oleic acid. In vitro data from differentiated human adipocytes suggest that chronic or intermittent exposure to oleic acid (MUFA) can induce a greater NF-κB-activated inflammatory response than eicosapentaenoic acid (PUFA) in that cell model. This finding underscores the complexity of isolating MUFA-specific effects in vivo.

5.6 Body Weight and Adiposity

Evidence Strength: Preliminary to Moderate; signals from large dietary pattern trials, but isolated MUFA effects are difficult to separate.

Secondary analyses within the PREDIMED trial found that replacing proteins with MUFA or PUFA decreased the odds of becoming obese; estimates for daily substitution of one portion of red meat with white meat, oily fish, or white fish showed weight changes up to −0.87 kg; and increasing the intake of unsaturated fatty acids at the expense of SFA, proteins, and carbohydrates showed beneficial effects on body weight and obesity.

Studies have shown that substituting dietary monounsaturated fat for saturated fat is associated with increased daily physical activity and resting energy expenditure; more physical activity was associated with a higher oleic acid diet than with a palmitic acid diet.

Recent results from the PREDIMED study reveal that the Mediterranean diet supplemented with olive oil reduces central obesity and incidence of type 2 diabetes and cardiovascular disease.

5.7 Brain and Cognitive Health

Evidence Strength: Preliminary; largely observational and small-scale mechanistic studies.

Variations in dietary content of the saturated fatty acid palmitic acid (C16:0) and the MUFA oleic acid (C18:1 n-9, ω-9) have been linked to alterations in cognitive function in humans.

Based on the trajectory of change in cognitive function, global cognition and verbal memory were enhanced as a function of the MUFA/SFA ratio, particularly when comparing the extreme quintiles (ratio of 0.9 versus 1.3).

Previous literature suggests that a higher ratio of palmitic acid to oleic acid in the diet induces inflammation, which may result in deficient brain insulin signaling and, secondarily, impaired physical activity, sleep efficiency, and cognitive functioning; one randomized, cross-over trial in 12 female subjects comparing 3-week high-palmitate and high-oleate diets evaluated functional MRI using an N-back test of working memory, cytokine secretion, and plasma cytokine concentrations.

Brain activation during the high palmitate diet compared to the high oleate diet was increased in regions of the basal ganglia including the caudate and putamen (p <0.005). This is consistent with greater neural effort being required under a high-SFA dietary condition. Evidence in this area remains very preliminary and largely based on small cross-over studies and observational sub-analyses.

5.8 Cancer Risk

Evidence Strength: Preliminary and Inconsistent; no definitive causal evidence in humans.

In regard to monounsaturated fat, plant sources are recommended; the consumption of plant MUFAs, particularly from olive oil, has been associated with lower cancer risk.

Epidemiological studies have suggested that n-6 polyunsaturated fatty acids and saturated fats are more likely to increase the incidence of cancer, whereas monounsaturated fatty acids and n-3 polyunsaturated fatty acids appear to show the opposite trend.

However, the observational nature of this evidence, along with confounding from overall dietary patterns and the presence of other bioactive compounds in MUFA-rich foods (such as polyphenols in olive oil), makes it impossible to attribute any cancer-related associations specifically to MUFA content. Levels of oleic acid along with other monounsaturated fatty acids in red blood cell membranes were positively associated with breast cancer risk in at least one study, illustrating the complexity and inconsistency of findings in this domain.

6. Body Systems and Health Areas Associated with MUFAs

• Cardiovascular System: There is epidemiological evidence that dietary MUFAs have a beneficial effect on the risk of CHD; evidence from controlled clinical studies has shown that MUFAs favorably affect plasma lipids and lipoproteins, factors related to thrombogenesis, in vitro LDL oxidative susceptibility, and insulin sensitivity.
• Metabolic / Endocrine System: MUFA can improve blood lipid profiles, insulin sensitivity, and glucose control, while protecting β-cells against apoptosis.
• Immune / Inflammatory System: MUFAs can inhibit NF-κB and NLRP3 activation through direct binding to GPR120 or PPARs, and through AMPK phosphorylation.
• Neurological System: Variations in dietary MUFA (particularly oleic acid) have been linked to alterations in cognitive function in humans.
• Cell Membrane Structure: Fat can be a source of energy and helps the body use vitamins and other nutrients; the fat consumed also plays a role in hormone production and in how the body's cells are made and function.

7. Dosage Forms and Reported Dosages

MUFAs are not typically consumed as isolated supplements but rather as components of whole foods or oils. The following dosages have been specifically reported in the cited research literature:

• Olive oil (FDA Qualified Health Claim context): The FDA qualified health claim references eating about 2 tablespoons (23 g) of olive oil daily as potentially reducing the risk of coronary heart disease due to its monounsaturated fat content.
• Dietary proportion — high MUFA diet threshold: In randomized controlled trials, dietary regimens with a high amount of MUFA were defined as greater than 12% of total energy from MUFA, compared with those providing ≤12%.
• Dietary proportion — guideline ceilings: The Academy of Nutrition and Dietetics and the Canadian Dietetic Association both promote less than 25% MUFA of daily total energy consumption, while the American Heart Association sets a limit of 20% MUFA in their respective guidelines.
• Animal study dosage: In a prediabetic rat model, palmitoleic acid and oleic acid were each administered intragastrically at a dose of 100 mg/kg body weight for four weeks.
• Anti-inflammatory clinical diet: Intake of a high-MUFA (~20% of energy) diet for 12 weeks reduced postprandial MCP-1 and TNF-mRNAs in peripheral blood mononuclear cells compared to a high SFA diet.
• Avocado clinical servings (NHANES context): One-half an avocado (approximately 68 g) provides high-monounsaturated fatty acids (6.7 g) and 114 kcals.
• No specific MUFA DRI established: No dietary recommendations for monounsaturated fatty acids are given by the National Institute of Medicine, the United States Department of Agriculture, European Food Safety Authority, or the American Diabetes Association.

8. Safety Considerations and Interactions

Caloric Density

All fats contain 9 calories per gram of fat; this is more than twice the amount found in carbohydrates and protein. Even though the unsaturated fats are considered heart-healthy, they still contain nine calories per gram, so serving sizes of healthy fats must be considered to stay within the daily recommended calorie intake.

Dietary Context Matters

It is not sufficient to simply add foods high in unsaturated fats to a diet that is otherwise filled with unhealthy foods and fats; instead, saturated or trans fats should be replaced with healthier, unsaturated fats.

Historical emphasis on reducing total fat resulted in increased consumption of refined carbohydrates and added sugars, and avoidance of nutrient-dense foods rich in healthy unsaturated fats such as nuts, seeds, avocados, and vegetable oils. This cautionary history highlights that the replacement nutrient matters as much as the fat itself.

Source Matters: Plant vs. Animal MUFAs

A 2014 meta-analysis concluded that an elevated consumption of olive oil is associated with reduced risk of all-cause mortality, cardiovascular events, and stroke, while monounsaturated fatty acids of mixed animal and plant origin showed no significant effects. This suggests that the protective associations seen in studies may reflect the whole-food matrix of MUFA-rich plant foods rather than the MUFA fraction alone.

Trans-MUFA vs. Cis-MUFA

Mounting evidence has indicated that all fatty acids with a double bond in the trans configuration will promote higher LDL cholesterol and lower HDL cholesterol concentrations, so their intake is highly correlated with the progression of coronary heart disease; it is therefore important to consider cis-MUFA and trans-MUFA separately. Trans-MUFAs such as elaidic acid, which are structurally distinct from the naturally occurring cis-MUFAs, carry significantly different metabolic implications.

Potential for Insulin Resistance (Nuanced)

Some monounsaturated fatty acids, in the same way as saturated fats, may promote insulin resistance, whereas polyunsaturated fatty acids may be protective against insulin resistance. This reflects the evolving and sometimes contradictory nature of MUFA research, particularly in the context of individual MUFA species and overall dietary pattern.

Interactions with Drug Therapies

Evidence from observational studies and randomized clinical trials demonstrates that replacing saturated fat with carbohydrates — specifically refined — has no benefit on CVD risk; the results of randomized controlled trials of n-3 PUFA supplements on cardiovascular outcomes have been disappointing, theorized in part because such nutrients may have little additional effect on top of modern drug therapies for CVD. While this observation pertains primarily to PUFAs, it highlights a broader issue relevant to all dietary fat interventions: the difficulty of demonstrating benefit in populations already receiving pharmacological treatment for dyslipidemia.

Oxidative Stability and Processing

Further research is needed to better determine how different approaches to food processing, technology, stability/oxidation, and breeding/engineering of plants or animals may alter the overall health effects of PUFAs and MUFAs. The single double bond in MUFAs confers greater resistance to oxidative rancidity relative to PUFAs, making MUFA-rich oils such as olive oil more stable under typical culinary heating conditions.

Regulatory Status

Food manufacturers may voluntarily list the amount in grams per serving of monounsaturated fat and polyunsaturated fat on the Nutrition Facts label (under Total Fat), but they are required to list monounsaturated fat and polyunsaturated fat if a statement is made on the package labeling about such fats.

References

• Encyclopedia MDPI — Monounsaturated Fat
• Schwingshackl L et al. — Monounsaturated fatty acids, olive oil and health status: a systematic review and meta-analysis of cohort studies. Lipids in Health and Disease, 2014 (PMC4198773)
• Schwingshackl L, Hoffmann G — Effects of monounsaturated fatty acids on cardiovascular risk factors: a systematic review and meta-analysis. Annals of Nutrition and Metabolism, 2012 (PubMed 22142965)
• Schwingshackl L, Hoffmann G — Monounsaturated fatty acids and risk of cardiovascular disease: synopsis of the evidence. Nutrients, 2012
• Kris-Etherton PM et al. — Monounsaturated Fatty Acids and Risk of Cardiovascular Disease. Circulation, 1999
• Gillingham LG et al. — Dietary Monounsaturated Fatty Acids Appear Not to Provide Cardioprotection. PubMed Central
• Temme EH et al. — Effects of dietary monounsaturated fatty acids on lipoprotein concentrations. American Journal of Clinical Nutrition, 2003 (PubMed 12816770)
• Schwingshackl L, Strasser B, Hoffmann G — Effects of monounsaturated fatty acids on glycaemic control: a systematic review and meta-analysis. Annals of Nutrition and Metabolism, 2011 (PubMed 21912106)
• Qian F et al. — Metabolic Effects of Monounsaturated Fatty Acid-Enriched Diets in Type 2 Diabetes: A Systematic Review and Meta-analysis. Diabetes Care, 2016 (PMC4955926)
• Imamura F et al. — Effects of Saturated, Polyunsaturated, Monounsaturated Fat, and Carbohydrate on Glucose-Insulin Homeostasis. PLOS Medicine, 2016
• Ravaut G et al. — Monounsaturated Fatty Acids in Obesity-Related Inflammation. International Journal of Molecular Sciences, 2021 (PMC7795523)
• Boa-Sorte Silva N et al. — Dietary saturated fat and monounsaturated fat have reversible effects on brain function. Scientific Reports, 2016 (PMC5023067)
• Salas-Salvadó J et al. — Dietary Lipids and Cancer. PubMed Central (PMC3078250)
• Gu Z et al. — Dietary Fat and Cancer — Which Is Good, Which Is Bad. Cancers, 2020 (PMC7312362)
• Kim Y et al. — Protective Effects of Dietary MUFAs Mediating Metabolites against Hypertension Risk. Nutrients, 2019 (PMC6722700)
• Miklankova D et al. — The Different Insulin-Sensitising and Anti-Inflammatory Effects of Palmitoleic Acid and Oleic Acid in a Prediabetes Model. Journal of Diabetes Research, 2022 (PMC9489414)
• Julibert A et al. — Quality of Dietary Fat Intake and Body Weight within the PREDIMED Trial. Nutrients, 2019 (PMC6315420)
• Dreher ML, Cheng FW — Avocado Fruit on Postprandial Markers of Cardio-Metabolic Risk. Nutrients, 2018 (PMC6164649)
• Dreher ML, Davenport AJ — Hass Avocado Composition and Potential Health Effects. Critical Reviews in Food Science and Nutrition, 2013 (PMC3664913)
• Kris-Etherton PM et al. — A healthy approach to dietary fats: understanding the science and reducing consumer confusion. Nutrition Journal, 2017 (PMC5577766)
• Nishi K et al. — The Mediterranean Diet: From an Environment-Driven Food Culture to an Emerging Medical Prescription. International Journal of Environmental Research and Public Health, 2019 (PMC6466433)
• Gorzynik-Debicka M et al. — The Secrets of the Mediterranean Diet. Nutrients, 2020 (PMC6949890)
• Case-control study on high-MUFA and high-fiber diet on blood lipids. Food Science & Nutrition, 2024 (PMC11167160)
• MedlinePlus — Facts about monounsaturated fats (U.S. National Library of Medicine)
• U.S. FDA — Interactive Nutrition Facts Label: Monounsaturated and Polyunsaturated Fats
• Wikipedia — Monounsaturated Fat
• Wikipedia — Olive Oil
• Advances in Nutrition — MUFAs overview article
• Oliveira AM et al. — Effects of diets rich in MUFAs on the management of insulin resistance: A systematic review. Grasas y Aceites, 2023